Skip to search Skip to main content

Limited Submission Funding Opportunity for Texas A&M HSC Faculty and PIs

Damon Runyon Cancer Research Foundation

Damon Runyon Clinical Investigator Award

https://www.damonrunyon.org/for-scientists/application-guidelines/clinical-investigator

 

Limited Submission Program (LSP): This funding opportunity and the Limited Submission Program (LSP) is open to all Texas A&M Health Science Center faculty and principal investigators who meet the eligibility requirements. Texas A&M and The Texas A&M University System agencies jointly administer this process to select the proposal(s) that will be submitted to the sponsor in response to this solicitation.

 

Institutional Eligibility:  Applications will only be accepted from institutions that have been invited to submit them by the Foundation (See list). Five (5) nominations per institution

 

  • PI Eligibility:  The applicant must be a U.S. citizen or permanent legal resident.
  • The applicant must hold an independent assistant professor position or equivalent. 
  • Each applicant must be nominated by their institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation (See list). Five (5) nominations per institution, including its affiliated schools, will be accepted. 
  • The applicant must have received an MD, DO, or MD/PhD degree(s) from an accredited institution, completed their subspecialty training and be U.S. Board eligible.
  • The applicant must hold a valid, active U.S. medical license at the time of application.
  • The applicant must apply within the first five (5) years of their initial full faculty appointment (Cut-off date: July 1, 2015). Adjunct or acting positions are not eligible.
  • Candidates holding or awarded R01s at the time of application are not eligible to apply.
  • The applicant must commit to spending 80% of their time conducting research. [In rare unique circumstances, the CIA Committee may consider an applicant with a very modest reduction of 80% protected time if their Department Chair can provide a compelling reason explaining why a waiver of the 80% requirement should be granted, what percentage of effort will be guaranteed, and what safeguards will be put in place to make sure the individual’s research will not be compromised by their clinical/administrative activities.]
  • The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award.  No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.
  • Candidates may apply up to three times during this eligibility period. 
  • Only one application will be accepted from a Mentor per review session (including Co-Mentorships).

 

The proposal will be prepared and submitted by Sponsored Research Services (SRS).

 

Proposal Limit: 5

 

Summary:  The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. 

 

The Clinical Investigator Award responds to three recognized realities:

  • Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
  • The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
  • The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.

 

The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.

The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.

 

DEFINITION OF CLINICAL RESEARCH

a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers.


b) Epidemiologic and behavioral studies.


c) Outcomes research and health services research.

 

Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients.  In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.

 

Preference will be given to research that adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients.

 

Dates:

 

November 27, 2019

Deadline for an email of intent including the title of the internal proposal and a one to three sentence description of the project. 

 

Send email of intent to limitedsubmissions@tamu.edu

December 9, 2019

Deadline to submit an internal proposal.

All proposals for the LSP must be submitted electronically using the e-proposal on-line application system.

Be prepared to upload your internal proposal. The sections will include a research plan summary (3 pages max not including references), two-page bio-sketch (per PI), and preliminary budget.

The e-proposal site is password protected. Texas A&M HSC principal investigators may use their NetID and password to access the system. If you do not have a NetID, click HERE for help to activate your NetID. You will need your UIN and your date of birth.  Once you log-in to e-proposal, choose “Limited Submission Grant” from the Available Grants section.


If you have any questions, please contact:

 shelly.martin@tamu.edu  or 979.862.2233.

January  8, 2020

Target date for the notifications to PIs of the result of the internal competition.

February 3, 2020

Sponsor deadline for the full proposal.

 

 

Internal Selection Procedures:

Texas A&M has established a procedure to identify limited submission opportunities and internally select proposals for Texas A&M submissions.  Please contact us if you have any questions about the limited submission process.